FDA Approvals in Oncology: January-March 2026
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
March is Colorectal Cancer Awareness Month. About 134,490 people are estimated to be diagnosed with and about 49,190 are...
In the first post of the "Meet the Chairs" series, Scott Armstrong, MD, PhD, program chair of the 2016...
While the incidence of many cancer types is decreasing, endometrial cancer—a type of cancer that begins in the uterus...
Guest Post by Lee Gibbs Associate member of the American Association for Cancer Research (AACR) and doctoral candidate at the...
In a study published in the AACR’s journal Cancer Discovery in December, a team of researchers from the Perelman...
At the end of last week, the U.S. Food and Drug Administration (FDA) approved the immunotherapeutic obinutuzumab (Gazyva) for...
Josette Northcott, PhD, is exploring the role that blood vessels play in the growth of tumors and the delivery...
With the theme of “Shaping the Future of Cancer Prevention: A Roadmap for Integrative Cancer Science and Public Health,”...
Because February is National Cancer Prevention Month and indoor tanning can dramatically increase a person’s skin cancer risk, melanoma...
Guest Post by Emer Smyth, PhD Assistant Director for the Stand Up To Cancer (SU2C) translational research grant programs, AACR